Cargando…
The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?
IgA nephropathy (IgAN) is the most commonly diagnosed primary glomerulonephritis worldwide. It is a slow progressing disease with approximately 30% of cases reaching end-stage kidney disease within 20 years of diagnosis. It is currently only diagnosed by an invasive biopsy and treatment options are...
Autores principales: | Pawluczyk, Izabella Z. A., Selvaskandan, Haresh, Barratt, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198207/ https://www.ncbi.nlm.nih.gov/pubmed/34071162 http://dx.doi.org/10.3390/jcm10112369 |
Ejemplares similares
-
A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression
por: Pawluczyk, Izabella, et al.
Publicado: (2021) -
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
por: Selvaskandan, Haresh, et al.
Publicado: (2018) -
New strategies and perspectives on managing IgA nephropathy
por: Selvaskandan, Haresh, et al.
Publicado: (2019) -
New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy
por: Scionti, Katrin, et al.
Publicado: (2021) -
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
por: Selvaskandan, Haresh, et al.
Publicado: (2020)